Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 89-25-8
- Molecular formula
- C10H10N2O
- Molecular weight
- 174.20 g/mol
- Drug class
- Free-radical scavengerantioxidant neuroprotective small molecule
- Mechanism of action
- The mechanism by which edaravone produces clinical benefit in amyotrophic lateral sclerosis (ALS) is not fully understood. It scavenges free radicals and may reduce oxidative stress and lipid peroxidation; these effects should not be equated with a proven disease-modifying molecular pathway.
- Indications / reported uses
- Treatment of amyotrophic lateral sclerosis (ALS) in adults under the US product indication; the clinical benefit is described as slowing decline in physical function in the studied population
Identification source: PubChem record (CID 4021). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.